Naloxone Distribution Project
DID YOU KNOW? The U.S. Food and Drug Administration (FDA) has approved an extended shelf-life for the nasal spray formulation of naloxone (Narcan) from two years to three years.
The Naloxone Distribution Project (NDP) is funded by SAMHSA and administe red by DHCS to combat opioid overdose-related deaths throughout California. The NDP aims to address the opioid crisis by reducing opioid overdose deaths through the provision of free naloxone, in its nasal spray formulation. Since October 2018, the NDP has distributed over 600,000 units of naloxone, and recorded over 30,000 overdose reversals.
Access the NDP application form. Please review the below table and FAQs for any additional required materials for your organization.
All NDP applicants must submit a prescription or standing order for naloxone. If your organization does not have a standing order, one can be obtained from the California Department of Public Health's website. When you submit your request for a Standing Order to Dept. of Public Health (when you click the submit button) it generates a document that you have to save as a PDF or Word document on your desktop and then submit a copy to DHCS.
Eligible entities must submit the following materials for application approval:
| Organization Type | Required Materials |
- First responders, fire, EMS
- Law enforcement, courts, & criminal justice partners
- Community organizations, Harm reduction organizations, homeless programs, veteran organizations, religious organizations
- Schools, universities, libraries
- County public health or behavioral health agencies
| - Completed NDP application
- A copy of a naloxone standing order or physician's prescription.
- A copy of a valid and active business license, FEIN number or tax-exempt letter.
- Distribution plan (for orders over 48 units)
- Number of overdose reversals reported with naloxone received through NDP (for subsequent applications)
|
| Substance Use Treatment Programs (inpatient, outpatient, residential) | - Completed NDP application
- A copy of a naloxone standing order or physician's prescription.
- A copy of a valid and active business license, FEIN number or tax-exempt letter.
- Copy of the program's DHCS license (if applicable)
- Policies and procedures for naloxone distribution, including:
- Separate storage of naloxone received through the program from other medications that may be billed to patient insurance;
- Inventory and tracking of naloxone received through the program;
- Distribution plan for naloxone received through the program
- Number of overdose reversals reported with naloxone received through NDP (for subsequent applications)
|
| Hospitals and Emergency Departments | - Completed NDP application
- A copy of a naloxone standing order or physician's prescription.
- A copy of a valid and active business license, FEIN number or tax-exempt letter.
- Signed Naloxone Terms & Conditions Form for Emergency Departments (Terms and Conditions form)
- Policies and procedures for naloxone distribution
- Number of overdose reversals reported with naloxone received through NDP (for subsequent applications)
|
More questions? Refer to the NDP Information & FAQs
Please maintain detailed distribution logs and reversal reporting documentation – DHCS may require review of this additional information prior to approving subsequent applications. If applicable, provide your policies and procedures for storage, adequate staffing, details of distribution plans and reversal reporting to avoid delays in processing applications.
NDP Resources
NDP Overview
NDP Information & FAQs
NDP Patient Discharge Terms & Conditions
Contact Us
Questions? Contact NDP Team by email: Naloxone@dhcs.ca.gov
